During the past decade, Hoag Family Cancer Institute conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hoag Family Cancer Institute" #1 collaborator was "Translational Drug Development" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hoag Family Cancer Institute" are "Cancer of the Prostate" (1 trials), "Castration-resistant Prostate Cancer" (1 trials), "HER2-expressing Cancers" (1 trials), "Metastatic Prostate Cancer" (1 trials) and "Pancreatic Cancer, Adult" (1 trials). Many other conditions were trialed in "Hoag Family Cancer Institute" in a lesser frequency.

Most popular intervention types in "Hoag Family Cancer Institute" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Capecitabine" (1 trials), "Enzalutamide" (1 trials), "GP-2250" (1 trials), "I-131-1095" (1 trials) and "Paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hoag Family Cancer Institute" are 2 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hoag Family Cancer Institute". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Hoag Family Cancer Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hoag Family Cancer Institute, 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".